Similar articles for PMID: 35365559

Year	Number of Results
2007	1
2008	1
2009	3
2010	5
2011	3
2012	3
2013	8
2014	9
2015	5
2016	17
2017	12
2018	12
2019	9
2020	9
2021	12
2022	7
2023	3

1

Anemia of chronic kidney disease: Will new agents deliver on their promise?

Souaid T, Taliercio J, Simon JF, Mehdi A, Nakhoul GN. Souaid T, et al. Cleve Clin J Med. 2022 Apr 1;89(4):212-222. doi: 10.3949/ccjm.89a.21100. Cleve Clin J Med. 2022. PMID: 35365559 Free article. Review.

2

Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: Advantages and disadvantages.

Mima A. Mima A. Eur J Pharmacol. 2021 Dec 5;912:174583. doi: 10.1016/j.ejphar.2021.174583. Epub 2021 Oct 19. Eur J Pharmacol. 2021. PMID: 34678238 Review.

3

Effect of hypoxia-inducible factor-prolyl hydroxylase inhibitors on anemia in patients with CKD: a meta-analysis of randomized controlled trials including 2804 patients.

Wang B, Yin Q, Han YC, Wu M, Li ZL, Tu Y, Zhou LT, Wei Q, Liu H, Tang RN, Cao JY, Lv LL, Liu BC. Wang B, et al. Ren Fail. 2020 Nov;42(1):912-925. doi: 10.1080/0886022X.2020.1811121. Ren Fail. 2020. PMID: 32869703 Free PMC article.

4

Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?

Souza E, Cho KH, Harris ST, Flindt NR, Watt RK, Pai AB. Souza E, et al. Expert Opin Investig Drugs. 2020 Aug;29(8):831-844. doi: 10.1080/13543784.2020.1777276. Epub 2020 Jun 16. Expert Opin Investig Drugs. 2020. PMID: 32476498 Review.

5

Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors.

Sugahara M, Tanaka T, Nangaku M. Sugahara M, et al. Pharmacol Ther. 2022 Nov;239:108272. doi: 10.1016/j.pharmthera.2022.108272. Epub 2022 Aug 27. Pharmacol Ther. 2022. PMID: 36031160 Review.

6

Anemia of chronic kidney disease: Treat it, but not too aggressively.

Nakhoul G, Simon JF. Nakhoul G, et al. Cleve Clin J Med. 2016 Aug;83(8):613-24. doi: 10.3949/ccjm.83a.15065. Cleve Clin J Med. 2016. PMID: 27505883 Free article. Review.

7

New Treatment Approaches for the Anemia of CKD.

Bonomini M, Del Vecchio L, Sirolli V, Locatelli F. Bonomini M, et al. Am J Kidney Dis. 2016 Jan;67(1):133-42. doi: 10.1053/j.ajkd.2015.06.030. Epub 2015 Sep 12. Am J Kidney Dis. 2016. PMID: 26372086 Review.

8

Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors.

Locatelli F, Minutolo R, De Nicola L, Del Vecchio L. Locatelli F, et al. Drugs. 2022 Nov;82(16):1565-1589. doi: 10.1007/s40265-022-01783-3. Epub 2022 Nov 9. Drugs. 2022. PMID: 36350500 Free PMC article. Review.

9

Emerging drugs for treatment of anemia of chronic kidney disease.

Magwood JS, Lebby A, Chen B, Kessler S, Norris L, Bennett CL. Magwood JS, et al. Expert Opin Emerg Drugs. 2013 Dec;18(4):421-9. doi: 10.1517/14728214.2013.836490. Epub 2013 Sep 16. Expert Opin Emerg Drugs. 2013. PMID: 24033253 Review.

10

Renal anemia: current treatments and emerging molecules.

Heras-Benito M. Heras-Benito M. Rev Clin Esp (Barc). 2023 Aug-Sep;223(7):433-439. doi: 10.1016/j.rceng.2023.06.006. Epub 2023 Jun 20. Rev Clin Esp (Barc). 2023. PMID: 37348652 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year